Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Publication of offer document

Correction Notice - with the correct attachment.NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR TO ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION. With reference to the announcement of 27 April 2023 regarding the entering into of a binding agreement between Deutsche Börse AG (Deutsche Börse) and SimCorp A/S (SimCorp or the Company), pursuant to which Deutsche Börse will make an all-cash voluntary recommended public takeover offer to acquire all of the issued and outstanding shares (except

LINK Arkitektur AB wins contract designing new buildings within advanced healthcare

Region Skåne has awarded LINK Arkitektur AB a contract for the construction of the new hospital buildings in Malmø, Sweden. The winning architectural team has been awarded a contract for the pre-design that includes all architectural disciplines. The pre-design phase will begin during the third quarter of 2023 and last for approximately 2 years. The contract includes options for detailed design and follow-up in construction phase. The value of the contract to the Multiconsult group is approximately NOK 33 million (NOK 80 million including options).The winning team consists of LINK

BioStock: Full speed ahead for BiBBInstruments after FDA clearance

2022 was intensive in terms of regulatory work for BiBBInstruments. The work started paying off in March this year when the medical technology company was awarded FDA clearance for the company's most important product, EndoDrill GI. The FDA clearance opened the door to the world's largest market for ultrasound-guided endoscopy. This also means that BiBB is a step closer to reaching a global distribution agreement. Looking ahead, clinical market activities in the US and a clinical multicentre study in pancreatic cancer in Sweden are expected.Read the article at biostock.se: https://www.

Limited-edition sample box from Holmen Iggesund sparks packaging dialogue

Holmen Iggesund’s new sample box, Touching Tomorrow, invites customers to discover materials, techniques and designs through a portfolio featuring the works of some very talented photographers and printing experts. Choosing the right packaging material is crucial for brands, not only to cater for the demands of their product, but to meet environmental targets as well. Holmen Iggesund’s new sample box guides and inspires brand owners in making the right selection and helps them to be a part of what’s next in packaging. “We wanted to explore how the packaging of tomorrow might

Zound continues its profitable growth journey in historic first quarter

Zound Industries continued its strong revenue and profit growth journey into the first quarter of 2023, with net sales increasing 54% to SEK 857.4 million. Operating profit increased to SEK 173.8 million (70.6), amounting to an operating margin of 20.3%, up from 12.7% in the same period last year. Zound also announced the acquisition of Marshall Amplification to create the Marshall Group, which will enable the company to further expand into the multi-billion-dollar global audio-tech industry.“The first quarter was an historic chapter for Zound. In addition to delivering our third best

Alma Media enables measuring of digital advertising carbon footprint as a first Finland based publisher

Alma Media Corporation                 Press Release              25 May 2023 ALMA MEDIA ENABLES MEASURING OF DIGITAL ADVERTISING CARBON FOOTPRINT AS A FIRST FINLAND BASED PUBLISHER Alma Media is the first Finland based publisher to offer its advertisers a carbon footprint calculation of digital campaigns. Greenhouse gas emissions generated by advertising published on Alma Media's ad network are reported to customers on a promotion-by-campaign basis.    The measurement looks at the emissions related to advertising from the complete supply path of the campaign. The calculation of

Neste to set the first science-based targets for nature as part of the selected pilot group by the Science Based Targets Network

Neste Corporation, News, 25 May 2023Neste is selected to the initial target validation group for science-based targets (SBTs) for nature, by The Science Based Targets Network (SBTN), which is aiming to set the global standard for ambitious and measurable corporate action on nature. Globally, only 17 companies are invited to the target validation group to pilot a global framework for setting targets, and measuring and validating organizations’ nature work.   “We are excited to be included in the initial target validation group. Biodiversity is an important part of our

Wärtsilä to deliver lab engine to SIMAC to support development of maritime skills

Wärtsilä Corporation, Press release, 25 May 2023 at 10:00 AM EESTTechnology group Wärtsilä has signed a contract to deliver a Wärtsilä 20  engine to SIMAC, Denmark’s leading maritime education centre. The intention is to operate and maintain the engine as part of SIMAC’s machinery laboratories, while at the same time deliver power to the local utility grid. The order will be booked by Wärtsilä in June 2023. The Svendborg International Maritime Academy’s (SIMAC) new laboratory will be designed around the Wärtsilä engine and will include a control room and needed

External revenue increase of 18% despite difficult market conditions

Inside information Interim financial report for Q1 2023Today, LED iBond International’s (LED iBond) Board of Directors approved the interim report for Q1. Martin Løbel, CEO of LED iBond international comments: “It is positive that LED iBond continue to increase revenue from external customers in a difficult market. I’m also pleased to see that we improved EBITDA by TDKK 906 and reduced our cash burn by 50%. In Q1, we have developed improved solutions for both indoor farming market and smart building. The market and customer awareness are increasing due to focused marketing activities,

Freetrailer Group A/S Quarterly report Q3 2022-2023

After a Q3 with 10% revenue growth, Freetrailer sees positive signs of increased rental activity in Q4, especially in our international markets.In Q3 22/23, the number of rentals increased by 9% compared to the same period last year, and revenue grew by 10% compared to Q3 21/22. Freetrailer Group A/S presents a financial report for the first nine months of the fiscal year from July 1, 2022, to June 30, 2023.  Q3 GROUP KEY FIGURES IN DKK 1,000 (1 January 2023 - 31 January 2023)(the corresponding period last year is indicated in brackets) · Revenue 17,029.2 (15,483.2) ·

Strategy Update: Following a successful AGM, DecideAct aims to break even in 2024 after emerging stronger from a turbulent 2022

Yesterday, DecideAct held its annual general meeting, where the company’s CEO, Flemming Videriksen, took stock of 2022 and gave an update on the strategy. In 2022, DecideAct passed DKK 10 million in ARR, and the year thus marked the end of the company's first 10x growth journey. This result was achieved in a year when SaaS companies in general were severely challenged. Now DecideAct aims to break even in 2024.At the end of 2022, the growth in ARR was 37% gross and 14% net after churn. Like other SaaS companies, DecideAct was affected by many companies taking a step back and cutting their

BioStock: Alligator Bioscience awarded Orphan Drug Designation for mitazalimab

Lund-based Alligator Bioscience continues to increase the value of its lead asset mitazalimab. The company recently announced receiving Orphan Drug Designation for the CD-40 antibody from the FDA. BioStock contacted Jonas Henningsen, VP Regulatory Affairs at Alligator, and CEO Søren Bregenholt, to learn more about what this means for the project.Read the interview with Jonas Henningsen and Søren Bregenholt at biostock.se: Alligator Bioscience awarded Orphan Drug Designation for mitazalimab - BioStock 

Inhalation Sciences receives 125,000 EURO funding in cross-European research project on inhaled antibiotics and antibiotic resistance

(Stockholm, 25 May, 2023) Inhalation Sciences (ISAB) has been awarded 125,000 EURO for its role in the research project ‘New Inhalation Formulations for Improved Delivery of Antimicrobials’ (APRINHA). ISAB is one of seven organizations collaborating on this project, including RISE (the Research Institutes of Sweden.) ISAB announced that it had collaborated with RISE on a joint funding proposal for the project on June 9, 2022. The project will run for 36 months. It is being coordinated by the University of Zurich (UZH).The unmet need for a targeted, efficacious inhaled antibiotic treatment

INTERIM REPORT JANUARY 1st 2023 – MARCH 31st 2023

SELECTIMMUNE PHARMA IN BRIEF   · Antibiotic resistance is a global, rapidly growing health concern. The World Health Organization (WHO) has declared antibiotic resistance a major threat to global health. · SelectImmune Pharma is an innovative biotech company that develops novel therapies against infection. · These therapies are designed to inhibit excessive innate immune responses to infection, which are a major cause symptoms and pathology. · Several of the company’s drug candidates have shown protective effects against bacterial infection in animal models, including

Interim Report January – March 2023

ChromoGenics delivers to Denmark and begins cooperation in FranceQ1 2023 In Q1 2023, ChromoGenics’ net sales amounted to SEK 5.8 (8.5) million, a decrease of SEK 2.7 million compared to the corresponding quarter in 2022. The company made deliveries during the first quarter to, among others, Franska Skolan in Copenhagen, Denmark, which impacted net sales by SEK 2.5 million during the quarter. ChromoGenics’ operating loss for the first quarter of the year amounted to SEK -12.2(-16.8) million, which is an improvement of SEK 4.6 million compared to the corresponding period in 2022. The

Bluefors to acquire its distributor Rockgate, establishing direct presence in the Japanese cryogenics technology market

Publish Date: May 25, 2023, 9:00 EEST – 15:00 JST Helsinki, Finland; Tokyo, Japan   Bluefors, a leading Finnish manufacturer of cryogenic measurement systems, has today announced its acquisition of Rockgate, a distributor of cryogenic equipment, based in Tokyo, Japan. With the acquisition Bluefors will establish direct sales and service presence in the Japanese cryogenics technology market and expand its global footprint beyond Finland, Germany, the Netherlands, and USA.   “Rockgate became the first distributor for Bluefors in the early stages of our journey and they have

Catena Media announces share buybacks executed from 17 to 23 May 2023

Catena Media plc (LEI code: 549300609A73DL5C5Z86) repurchased 205,000 of its own ordinary shares (ISIN code: MT0001000109) from 17 to 23 May 2023 as part of its share buyback programme. The buyback programme (“the 2022 programme”) was authorised by shareholders at an extraordinary general meeting on 10 August 2022 and initiated and announced by the board of directors on 13 January 2023. The 2022 programme was implemented in accordance with the EU Market Abuse Regulation (EU) No 596/2014 ("MAR") and the Commission Delegated Regulation (EU) 2016/1052 (the "Safe Harbour Regulation"). Its

Kemira achieves EcoVadis Platinum level for the third consecutive year with an improved score of 80/100

Kemira Oyj, Press Release, May 25, 2023 at 9 am (EEST)  Kemira achieves EcoVadis Platinum level for the third consecutive year with an improved score of 80/100Kemira has once again achieved the Platinum level rating for its sustainability performance by EcoVadis, the global sustainability rating platform, for the third consecutive year. Kemira remains among the top 1% of companies rated worldwide, with a score increase of 2 points to 80/100 (compared to 78/100 in 2022) due to its progress in sustainable procurement through engagement with suppliers on climate-related issues as well as

Clinical Laserthermia Systems AB publishes interim report January – March 2023

Summary of the interim report (relates to the Group)   Three months (01/01/2023–03/31/2023) · Net sales totaled SEK 587,000 (SEK 708,000). · Profit/loss after financial items totaled SEK -21,464,000 (SEK -13,842,000). · Basic and diluted earnings per share totaled SEK -0.15 (SEK -0.21). · The equity ratio at March 31, 2022, was 7,5% (12%).     Significant events in the first quarter of 2023   · The twentieth and final patient was treated by the Urological Research Network, LCC, based in Florida, USA, in the phase 1 clinical trial using the CLS TRANBERG®

Interim report Q1 2023

First quarter January 1-March 31 2023 · Net sales amounted to 17,275 (8,217) kSEK, an increase of 110% compared to Q1 2022. · Operating profit before depreciation and amortization and shares in associated companies' earnings (EBITDA) amounted to -249 (963) kSEK after financial items amounted to -3,432 (-909) kSEK · EBITDA per share amounted to -0.01 (0.06) SEK · Earnings per share after financial items amounted to SEK -0.20 (-0.06) SEK · Cash and cash equivalents at the end of the quarter amounted to 17,893[1] (37,890) kSEK. This compares to 48,309 kSEK at the end of the

Eltel to install additional 664,000 smart meters in Sweden for SEK 585 million, about EUR 51 million

Eltel's Smart Grids business in Sweden has signed a new contract with Vattenfall Eldistribution AB to install 664,000 new-generation smart electricity meters across the country. The contract is worth SEK 585 million, about EUR 51 million.This contract is an extension of a previous agreement signed in February 2020, where Vattenfall Eldistribution AB decided to utilize the option to order remaining phases of smart electricity meter installations. As a result, throughout the project, Eltel will be installing a total of approximately 900,000 smart electricity meters and technology for about 40,

Dignitana AB Publishes Q1 2023 Interim Report

Revenue reaches record high with EBITDA positive Financial highlights Q1 2023 · Net sales amounted to 21.5 MSEK (15.9), an increase of 35 percent over the same period in 2022. · Operating result amounted to -3.5 MSEK (-6.1). · Net result after financial items amounted to -3.9 MSEK (-6.5). ·  Earnings per share were -0.06 SEK (-0.10). · Cash Balance amounted to 11.7 MSEK (11.3). · Average Daily Treatment Revenue (ADTR)* was 242 TSEK (179), an increase of 35 percent over the same period in 2022. · EBITDA positive for the period. Business highlights during the

Woodspin ramps up production of sustainable, wood-based SPINNOVA® fibre at new zero-emission factory

The first commercial facility producing SPINNOVA® fibre is scaling up production to 1,000 tonnes of sustainable textile fibre annually. 25 May, Jyväskylä, Finland – Finnish sustainable textile pioneer Spinnova and the world's largest pulp producer Suzano have officially opened their first commercial-scale facility producing wood-based SPINNOVA® fibre. Operated by Woodspin – Spinnova and Suzano’s joint venture – the plant will produce 1,000 tonnes of sustainable, recyclable and fully biodegradable textile fibre from responsibly-grown wood each year. This facility marks the first

Interim report for the period 1 January 2023 – 31 March 2023

published at 08:00 on 25 May 2023 Wicket Gaming AB (”Wicket Gaming” or the ”Company”) publishes interim report for the period 1 January 2023 – 31 March 2023.Summary of the period The Group arose during the fourth quarter of 2022. Consequently, the figures presented in this report for the Group do not include any comparison with the corresponding period in the previous year. First quarter 01/01/2023 – 31/03/2023 (Group) · Net sales: SEK 4,606 thousand. · Earnings before interest, taxes, depreciation and amortisation (EBITDA): SEK -2,329 thousand. · Net loss after

There are no items matching the current filter
There are no more items matching the current filter
Back to top